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Ultraviolet (UV) irradiation is a major factor in the pathogenesis of certain variants of cutaneous lupus erythematosus.
Photosensitivity constitutes one of the criteria of the American Rheumatism Association for the diagnosis of sys-
temic lupus erythematosus, which further emphasizes its importance. The pathomechanism of UV-induced lupus
erythematosus remains unknown. The characterization of photosensitive subacute cutaneous lupus erythematosus
(SCLE) by Gilliam and Sontheimer has led to a new approach. Through the development of standardized test methods
it has became possible to reproduce cutaneous lesions in the UV-A and UV-B spectrum. These standardized test
methods allow a better definition of photosensitivity than clinical history does. Recent clinical data show that besides
SCLE another variant, lupus erythematosus tumidus, also reveals pronounced photosensitivity. In this review article
phototest procedures, phototest results, and clinical correlations in different subgroups are discussed. J Invest
Dermatol 100:53S–57S, 1993
Kaposi observed that it was mostly outdoor workers that developed
lupus erythematosus (LE) and that cold weather, heat, and fire led to
exacerbations of the disease [1]. At the end of the last century several
other groups had already realized that environmental factors played a
central role in the induction of the disease [2–5]. As early as 1921 Nobl
observed a patient who developed lesions after artificial irradiation [6].
The first controlled phototesting with artificial ultraviolet (UV)
irradiation was performed by Epstein et al [7]. They studied 21 patients
with systemic lupus erythematosus (SLE) and four patients with DLE.
Using a hot quartz lamp as a UV-B source, they could reproduce
clinically and histologically abnormal reactions that lasted up to three
months in five cases by the application of doses equivalent to that which
would produce a grade 2 to 3 sunburn erythema. Because they could not
induce lesions beyond 320 nm, they suggested that the spectrum was in
the UV-B range. Baer and Harber studied 23 DLE and five SLE patients,
and one patient who would have been classified today as SCLE [8]. They
applied one to six times the minimal erythema dose (MED)-UV-B on
multiple test sites as single exposures. Only the SCLE patient showed
a pathologic reaction with a reduced minimal erythema dose
and persistence of the erythema. Freeman tested several patients in the
300-nm spectrum with an equivalent to eight times the erythema dose [9].
Cripps and Rankin determined the erythema action spectra and tried to
induce lesions with monochromatic light in the range of 250–330 nm [10].
The dose range was between eight and 13 times the MED. In their study
the first immunoglobulin deposits could be detected 8 weeks after UV
irradiation. Gilliam and Sontheimer’s description of subacute cutaneous
lupus erythematosus (SCLE) marks a major step forward in the
photobiology and the characterization of photosensitive variants [11].
Here SCLE was defined by clinical history, the SSA/Ro-antibody, and
the HLA-B8 and -DR3 phenotype. Again photosensitivity was defined
by clinical history. Further experiments evolving from these clinical
observations have led to the concept that keratinocytes damage by
antibody-dependent cellular cytotoxicity might be a mechanism in
photosensitive cutaneous lupus erythematosus (CLE) [12–14]. Although
the UV spectrum was believed to be in the UV-B range, several authors
observed exacerbations of LE after artificial irradiation in sun-tanning
studios where the radiation was more UV-A [15,16].
Furthermore, animal models and in vitro data give evidence for a
possible role of UV-A in UV-induced LE [17–22]. For this reason we
decided to do a study that, since 1986, has involved extensive
phototesting of every newly diagnosed LE patient in our clinic. This
review article will discuss the clinical phototest results and compare them
with recent data from literature.
PHOTOTESTING PROCEDURE
Patients with lupus erythematosus were routinely tested at the department of
dermatology, University of Du¨sseldorf. Clinical examination and laboratory
tests did not reveal any features of systemic disease at the time of testing.
The light sources used included an UVASUN 3000 high-pressure
metal halide lamp (330–460 nm, Mutzhas, FRG) for UV-A testing, and an
UV 800 lamp equipped with fluorescent bulbs Philips TL 20 W/12
(285–350 nm, Waldmann, FRG) for UV-B testing.
Determination of the minimal erythemal dose UV-B (MED UV-B),
threshold dose for immediate pigment darkening (IPD), and minimal
tanning dose (MTD) was carried out according to standard procedures.
Test reactions were read immediately following and 24h after irradiation.
For the provocative phototest two areas (5 8 cm) of uninvolved skin
on the back or on the extensor surface of the arms were irradiated with
100 J/cm2 UV-A or 1.5 MED UV-B on three consecutive days (Table I).
Other test areas such as the buttock did not give similar results and lesions
could not be reproduced in this area. Test areas were evaluated 24,48,
and 72 h and up to 3 weeks after the last irradiation [23].
Criteria for a positive provocative phototest were induced lesions
clinically resembled LE, histopathology compatible with LE, and skin
lesions developing slowly and persisting for several days.
The patients tested were asked if exposure to sunlight had any effect
on their disease, in order to evaluate the correlation between phototest
results and medical history. Statistical analysis to the evaluation of
photosensitivity and antibody profile was performed by contingency
coefficient C.
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PROVOCATIVE PHOTOTEST
The development of positive phototest reactions in LE was considerably
slower and persisted longer than phototest reactions in other photo-
dermatoses, i.e., polymorphous light reaction, persistent light reaction,
photoallergy, hydroa vacciniforme, and solar urticaria. Lesions developed
in general 48–96 h (range 24 h to 3 weeks) after irradiation and lasted
about 1 to 3 weeks (Fig 1). In some cases, induced lesions persisted for
several months. Only a few cases revealed hypopigmentation of the
lesions, a feature that can be observed in SCLE patients.
In our initial study, patients with SCLE showed the highest frequency
of positive provocative phototest reactions [23]. In 64% of patients with
SCLE, in 42% with DLE, and in 25% with SLE, skin lesions characteristic
for LE could be induced. Definitely positive test results were not, however,
found in 13% of all patients. About 53% of the patients in whom LE
lesions were induced reacted to both UV-B and UV-A, 33% reacted only
to UV-B, and 14% reacted only to UV-A. Thus in our experimental system
lesions could be reproduced in the UV-A as well as the UV-B spectrum.
Determination of the MED UV-B revealed that LE patients do not exhibit a
decreased threshold for UV-induced erythema compared to controls with
normal reactions. Although we did not study the duration of UV-B
erythema in particular, a prolonged erythematous response was not a
conspicuous feature.
However, we could sometimes observe induction of LE in test areas, in
which the MED UV-B was determined. As these reactions remain much
longer than UV-B erythema, previous investigators may have interpreted
incipient UV-induced LE lesions as persistent UV-B erythema. Similar to
MED UV-B the pigmentary responses IPD and MTD of LE patients were
within the normal range compared to a control group. In our study
photosensitivity in LE patients seems to be confined to exacerbation or
induction of specific lesions by UV irradiation. About 50% of all patients
were aware of an adverse effect of sunlight on their condition. Of these
patients 66% showed pathologic test reactions. In contrast, pathologic
reactions were induced in 46% of those patients who denied any effect of
sun exposure on their disease.
In the meantime we have extended our first study and looked more
closely at the possible link between the SSA/Ro-antibody and photo-
sensitivity. Furthermore we have included other subgroups of cutaneous
LE, such as lupus erythematosus tumidus (LET) [24]. Lupus erythematosus
tumidus is a variant of cutaneous lupus erythematosus which is not yet
well defined. Clinically, erythematous plaques without epidermal
involvement are seen on the face and trunk, especially the back. In
contrast to DLE, little epidermal involvement is seen histologically. There
is a superficial and deep perivascular and periadnexal lymphocytic
infiltrate with predominantly T-helper cells. Mucin between collagen
bundles can be present. In the absence of underlying systemic symptoms
it is sometimes difficult to differentiate from the infiltrate of Jessner
lymphocytic infiltration and polymorphous light eruption. LET is further
characterized by a slight male predominance and photosensitivity. Of 32
patients with LET, 22 had a positive test reaction. Of these, 14 reacted
only to UV-A, 17 only to UV-B, and nine to both. In our studies there was
no association between frequency of the SSA/Ro-antibody and photo-
sensitivity in any of the subgroups (Figs 2 and 3) [25].
Only 3% of the photosensitive DLE patients were Ro-positive. These
data are more obvious in LET. Not a single patient of this UV-sensitive
variant (81% UV positive) has the Ro-antibody. In SCLE (Fig 3),
UV-positive and UV-negative patients have the same frequency of the
Ro-antibody. Thus our data again show no relation between photo-
sensitivity and Ro-antibody.
HISTOPATHOLOGY AND IMMUNOHISTOCHEMISTRY
As the test procedure permits us to study the development of CLE
chronologically, biopsies were taken at different time intervals from DLE
and SCLE patients and studied by routine histopathology and immuno-
histochemistry [26]. (Teikemeier G, Goldermann R, Lehmann P, Goerz G,
Plewig G, Kind P: Chronological immunohistological studies of UV-A-
and UV-B-induced lesions of cutaneous lupus erythematosus (paper in
preparation).)
HISTOPATHOLOGY OF EARLY UV-INDUCED LESIONS
All biopsies taken up to day ten were defined as early lesions. Both
variants studied, DLE and SCLE, revealed a superficial perivascular
Figure 1. UV-A – and UV-B – induced lesions in an SCLE patient at day 10
after irradiation. Lesions could be induced in the UV-A (left side) and the UV-
B (right side) spectrum. Clinically lesions were compatible with LE. UV-A-
induced lesions showed small erythematosus plaques, whereas UV-B –
induced lesions were more papulosquamous.
Figure 2. Correlation between photosensitivity (measured by a standardized
testprotocol) [24,26], Ro/SSA-antibodies, and antinuclear antibodies in DLE
and LET. UV-negative LET patients showed more frequently antibodies than
UV-positive patients. Statistically there was no association between the
parameters (contingency-coefficient C).
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lymphocytic infiltrate with few interstitial cells in UV-A-and UV-B-
induced lesions. Vacuolar alteration of the dermoepidermal junction was
not observed (Fig 4).
HISTOPATHOLOGY OF LATE UV-INDUCED LESIONS
Biopsies taken after day ten were defined as late. UV-B-induced lesions of
SCLE and DLE showed a similar pattern. Parakeratosis, few necrotic basal
keratinocytes, and vacuolar alteration of the dermoepidermal junction
were the dominant features (Fig 5). A lichenoid infiltrate was found in the
upper dermis.
Mucin between collagen bundles was rarely detected. In contrast, UV-A-
induced lesions were characterized by fewer epidermal changes. Slight
smudging of the dermo-epidermal junction was observed in half of the cases.
A perivascular lymphocytic infiltrate was localized in the upper and mid-
dermis. Patients who were clinically photosensitive in the UV-A and the UV-
B range revealed abundant mucin between collagen bundles. SSA/Ro-
positive patients showed histologically more pronounced epidermal changes
such as parakeratosis, atrophy, necrosis, and vacuolar alteration.
IMMUNOHISTOCHEMISTRY OF EARLY
UV-INDUCED LESIONS
UV-A –UV-B – induced lesions of both subgroups showed predominantly
T-helper cells at the dermo-epidermal junction. Suppressor/cytotoxic T
cells, B cells, and Langerhans cells were not observed in this region. HLA-
DR expression of epidermal keratinocytes was observed rarely. The
dermal infiltrate of early lesions rarely showed IL-2 expression.
IMMUNOHISTOCHEMISTRY OF LATE
UV-INDUCED LESIONS
The dermo-epidermal junction of UV-A- and UV-B-induced DLE lesions
consistently showed T-helper cells. In both genuine and in UV-A – and
UV-B –induced SCLE lesions an increased number of suppressor/cytotoxic
T cells was observed. B cells were not detected in this region. The number
of Langerhans cells was reduced. In genuine lesions of both subsets, HLA-
DR expression on basal keratinocytes was increased. This was especially
observed in SCLE lesions, both UV induced and genuine.
The dermal infiltrate of both subtypes was primarily composed of T
cells. B cells and macrophages were rarely observed. The deeper dermal
infiltrate (predominantly DLE lesions) revealed a helper/suppressor ratio of
2:1. B cells, when present at all, were observed only in genuine and in late
UV-induced DLE. (Teikemeier G, Goldermann R, Lehmann P, Goerz G,
Plewig G, Kind P: Chronological immunohistological studies of UV-A-
and UV-B-induced lesions of cutaneous lupus erythematosus (paper in
preparation).)
DIRECT IMMUNOFLUORESCENCE
None of the UV-induced lesions showed immunoglobulin or complement
deposits at the dermo-epidermal junction or around vessels. Specifically,
UV-challenged skin of SCLE patients did not contain a pattern of
epidermal dust-like particulate IgG deposition. This is in accordance
with Cripps, who detected the first immunoglobulin deposits 6 weeks after
Figure 4. Histopathology of an early UV-A – induced lesion (day 5) from a
SCLE patient. No alteration of the dermo-epidermal junction. Sparse
superficial perivascular lymphocytic infiltrate with slight epidermotropism.
(Hematoxylin and eosin, magnification40.)
Figure 3. Correlation between photosensitivity (measured by a standardized
test protocol) [24,26], Ro-antibodies, and antinuclear antibodies in SCLE and
SLE. Statistically there was no significant association.
Figure 5. Histopathology of a late UV-B induced lesion (day 14) in an SCLE
patient. Thin epidermis with slight vacuolar alteration and smudging at the
dermoepidermal junction. Few necrotic keratinocytes. Lichenoid infiltrate in
the papillary dermis with epidermotropism. (Hematoxylin and eosin,
magnification 40.)
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irradiation [10]. We did not study biopsies that were taken later than 6
weeks after irradiation.
DISCUSSION
The role of UV irradiation in the pathogenesis of LE has been the subject
of many in vitro and in vivo studies over the last years [12–14,17–20,27].
To delineate the effects of different wavelengths, previous investigators
tried to reproduce LE lesions by exposure to artificial sources of UV
irradiation [7,8]. Due to different radiation sources, differing test
protocols, and the limited number of patients, conflicting results were
gained from these studies [7]. Nevertheless, most studies state that the
action spectrum of LE is confined to wavelengths shorter than 320nm.
However, we have shown that the action spectrum extends into the UV-A
range [23]. These data have been recently confirmed by other authors
[22,31,32].
The development of positive phototest reactions in LE has been
considerably slower than in other photodermatoses [23]. Because of the
latency period it may be difficult for the patients to link sun exposure to
skin lesions.
In our studies, the MED UV-B was not decreased and a prolonged
erythematous response was not observed. Other investigators observed a
lowered MED in the majority of their SLE patients and in part of their DLE
patients [32]. A long-lasting erythematous response was observed in SLE,
SCLE, and DLE patients [32]. These differences may be due to differing test
protocols. Time of reading might be essential because the development of
lesions often takes weeks. In our study, photosensitivity in LE patients
seems to be confined to exacerbation or induction of specific lesions by
UV irradiation.
There was a weak correlation between a positive history for UV
sensitivity and phototest reactions [23]. Normal test reactions were found
in 34% of patients who felt that they react abnormally to sunlight. Wolska
et al also found a positive correlation with sun sensitivity [32]. These
authors used a quite different test protocol. Induction of lesions was
observed after a single UV exposure. From our experience, however,
single UV exposure is unlikely to induce clinical lesions. This discrepancy
may be explained by inaccurate medical histories given by the patients,
by photosensitivity not being a permanent feature, or by provocative
phototesting still missing some of the UV-inducible cases.
In an ongoing study we have tested other subgroups of CLE patients.
Interestingly lupus erythematosus tumidus patients were even more
photosensitive than SCLE patients (Fig 6). These findings must be delved
into further, because of the difficult differential diagnosis. The large
number of photosensitive DLE patients in other studies might be due to an
overlap with the LET group.
Antibody-dependent cellular cytotoxicity is currently the most
important theory for photosensitive CLE [12,14]. For this patho-mechan-
ism an antibody such as the SSA/Ro-antibody in SCLE patients has to be
present in the serum.
As the standardized test procedure allows a much better definition of
photosensitivity, we have looked at the link between SSA/Ro-antibody
and photosensitivity. In our study the SSA/Ro-antibody is a marker for
SCLE, but there is no association between photosensitivity and frequency
of the SSA/Ro-antibody in any of the subgroups studied (Figs 2 and 3) [25].
These findings are confirmed by other groups [32,33]. Without
phototesting, Sutey observed photosensitivity in 4% of black SSA/ Ro-
positive patients and 55% in black SSA/Ro-negative patients. For white
SSA/Ro-positive patients, 87% were photosensitive; for SSA/Ro-antibody
negative patients only 57%. Today most studies show no correlation
between photosensitivity and SSA/Ro-antibody [32–34].
Detection of the Ro-antibody is dependent on the technique used,
which could explain these different frequencies of the antibody. Other
reasons could be variations in the titer, a different patient population, or a
different classification [35]. The most likely explanation is that there are
additional factors responsible for photosensitivity [24,27,28].
Biopsies of induced lesions taken at different time intervals also make
it possible to study the chronologic development of the lesions. Early
lesions of all groups showed a discrete perivascular T-helper cell infiltrate.
Velthuis could also demonstrate a superficial perivascular T-helper cell
infiltrate in the upper dermis [22]. Later on the T-helper cells have more
lichenoid features and in SCLE lesions more suppressor/cytotoxic T cells
were observed.
Lichenoid features are observed in a group of ‘‘graft-versus-host-like
diseases’’ such as lichen planus, graft-versus-host disease, and LE. For
these diseases it has been suggested that the epidermal cell damage is the
result of a T-lymphocyte – mediated attack on epidermal cell antigens
[36]. Interestingly, in contrast to DLE, late SCLE lesions showed more
CD8-positive cells in the upper dermis. Whereas in early lesions HLA-DR
expression seems to be reduced by UV light, in later stages, especially in
SCLE, keratinocytes express HLA-DR antigens on their surface. This
observation suggests that HLA-DR-positive keratinocytes might stimulate
epidermotropic T cells to release additional lymphokines such as IFN-y,
resulting in augmentation of epidermal cell damage. Conceivably, some
cell-surface molecules become immunogenic to helper T cells when la
antigens are co-expressed on the membrane of keratinocytes [36,37].
Unfortunately in our system we cannot rule out that HLA-DR expression is
secondary to epidermotropic cells. Thus, especially in SCLE, HLA-DR-
bearing keratinocytes could play an important role in the perpetuation of
epidermal cell damage mediated by HLA-DR recognizing T cells.
The data in the literature on direct immunofluorescence differ. In this
study and in an older report no immunoglobulin or complement deposits
could be detected in early UV-induced lesions [9,10], whereas in a recent
study granular deposits were detected in 12 of 16 UV-induced lesions
[22]. The presence of immunoglobulin deposits in the early phase of CLE
is therefore still controversial. Humoral autoimmunity is somewhat
unlikely, because the negative immunofluorescence and the late presence
of very few B cells militate against a localized immunoglobulin
production [38].
Although numerous new data have been accumulated, the pathophy-
siology of photosensitive CLE is still unknown. Photosensitivity in LE is in
Table I. Testprotocol for the Reproduction of
Cutaneous Lesions [24,26]
Location Upper back or arm
Size of testfield 5 8 cm
Lightsource UVASUN 3000 (330–460nm) Mutzhas
UV 800, Philipps TL 20 W/12
(285–350 nm), Waldmann
UV-dose 3 1.5 MEDUV-B
Reading 24, 48, 72 h up to three weeks
Figure 6. Photosensitivity in different subgroups of LE measured by our
standardized test protocol [24,26]. Photosensitivity was most pronounced in
SCLE and LET.
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the UV-A and UV-B spectrums. It is dependent on local factors such as the
site of the lesion. The presence and density of an antigen such as the SSA/
Ro antigen could vary at different body sites [39]. A serum factor is
essential for the photosensitivity in some variants of CLE [27,28].
SSA/Ro-positive SCLE patients have an increased photosensitivity and
show more damage to the dermo-epidermal junction. In addition, LET, a
not well characterized variant, might be even more photosensitive. Thus
the current clinical and experimental data suggest different but possibly
overlapping mechanisms for photosensitive CLE.
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